TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27785737

Group type: EXPERIMENTAL
Intervention: Entospletinib (25-1200 mg; fasted) as single or twice-daily oral doses for 7 days
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Entospletinib (≥600 mg twice daily)
Number of subjects: 120
Study: 26520218

Group type: EXPERIMENTAL
Intervention: Group Triple P Program with additional father‐relevant content
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 42
Study: 24570981

Group type: EXPERIMENTAL
Intervention: 6 mm long and 4 mm wide implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Implants at least 10 mm long in augmented bone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6 mm long implants
Number of subjects: 40
Study: 21742400

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT), administered twice per week for a total of six treatments.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Hyperbaric oxygen therapy (HBOT), administered daily for a total of 20 treatments.
Number of subjects: 77
Study: 19520125

Group type: EXPERIMENTAL
Intervention: Expectations confirmed about food and emotion with positive mood induction
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Expectations disconfirmed about food and emotion with negative mood induction
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Positive mood induction
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Negative mood induction
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study: 16772765

Group type: EXPERIMENTAL
Intervention: 200 mg celecoxib twice a day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 250 mg acetazolamide twice a day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo twice a day
Number of subjects: 10
Study: 15309644

Group type: EXPERIMENTAL
Intervention: Hydropneumatic anal dilation (HAD)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Topical nitroglycerin (GTN)
Number of subjects: 109
Study: 11904978

Group type: EXPERIMENTAL
Intervention: rhuMAb‐E25 (recombinant humanized monoclonal anti‐IgE antibody)
Number of subjects: 0
Study: 9818888

Group type: EXPERIMENTAL
Intervention: Antimigraine therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nitroglycerin ointment test
Number of subjects: 42
Study: 7622802

Group type: EXPERIMENTAL
Intervention: 150 mg remoxipride
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 3 mg haloperidol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 1978501

Group type: EXPERIMENTAL
Intervention: Remoxipride
Number of subjects: 92

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 92
Study: 606774

Group type: EXPERIMENTAL
Intervention: Whole-virus vaccines
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Split-product vaccines
Number of subjects: 110

Group type: COMPARATOR
Intervention: Whole-virus vaccines and split-product vaccines
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 7081917

Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple tube drainage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 0
Study: 29096584

Group type: EXPERIMENTAL
Intervention: Routine psychotherapy
Number of subjects: 9895

Group type: EXPERIMENTAL
Intervention: Routine psychotherapy for clients with initial severity similar to RCT participants
Number of subjects: 9895

Group type: EXPERIMENTAL
Intervention: Routine psychotherapy for moderately distressed clients
Number of subjects: 9895

Group type: EXPERIMENTAL
Intervention: Routine psychotherapy for severely distressed clients
Number of subjects: 9895
Study: 28795452

Group type: EXPERIMENTAL
Intervention: Resistance training (chest and leg press exercises, three sets, eight repetitions, 80% predicted one-repetition maximum)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 43
Study: 26722141

Group type: EXPERIMENTAL
Intervention: Home-visit group
Number of subjects: 182

Group type: COMPARATOR
Intervention: Telephone follow-up group
Number of subjects: 182

Group type: COMPARATOR
Intervention: As-usual care group
Number of subjects: 182
Study: 25104523

Group type: EXPERIMENTAL
Intervention: CABG plus medical therapy
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 1212
Study: 22800663

Group type: EXPERIMENTAL
Intervention: Post-M + C
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Post-M + C + P
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Post-M
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Post-P
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Post-C
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: M + C
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: M + P
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: M + C + P
Number of subjects: 108
Study: 20598849

Group type: EXPERIMENTAL
Intervention: ATP infusions (50 μg/kg.minute, 8-10 hours/week for eight weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no ATP)
Number of subjects: 99
Study: 18060956

Group type: EXPERIMENTAL
Intervention: Backfill-assisted voiding trial
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spontaneous voiding trial
Number of subjects: 60
Study: 15598450

Group type: EXPERIMENTAL
Intervention: Normal knees
Number of subjects: 15

Group type: COMPARATOR
Intervention: ACLD knees
Number of subjects: 15
Study: 12052458

Group type: EXPERIMENTAL
Intervention: Fed state (breakfast at 08:00 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fasting state (no breakfast)
Number of subjects: 20
Study: 10431463

Group type: EXPERIMENTAL
Intervention: Markov model with minimum order
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Heart rate, pNN30, and LF/HF index plots
Number of subjects: 7
Study: 7769367

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic hormone (ANH) at low dose (0.6 pmol/kg/min)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic hormone (ANH) at medium dose (1.8 pmol/kg/min)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic hormone (ANH) at high dose (5.4 pmol/kg/min)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 11
Study: 2178657

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 7021452

Group type: EXPERIMENTAL
Intervention: Flutroline 20 mg daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Flutroline 100 mg daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Flutroline 1 mg daily
Number of subjects: 25
Study: 30830974

Group type: EXPERIMENTAL
Intervention: MDT assessment of T category
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MDT assessment of N category
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MDT assessment of M category
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MDT assessment of resectability
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MDT treatment allocation agreement
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MDT treatment allocation agreement (Krippendorff's α)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MDT treatment allocation where resectability assessments were concordant
Number of subjects: 19
Study: 28748412

Group type: EXPERIMENTAL
Intervention: DFN-15 120 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DFN-15 180 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DFN-15 240 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Celecoxib 400-mg oral capsules
Number of subjects: 16
Study: 25971957

Group type: EXPERIMENTAL
Intervention: 2 ml of 4 mg ondansetron
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (2 ml normal saline)
Number of subjects: 50
Study: 23417765

Group type: EXPERIMENTAL
Intervention: Blonanserin under fasting (single dose 4, 8, and 12 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Blonanserin under food intake (single dose 8 mg)
Number of subjects: 50
Study: 21236333

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500mg twice per day)
Number of subjects: 0
Study: 18783388

Group type: EXPERIMENTAL
Intervention: On-demand treatment with esomeprazole 20 mg
Number of subjects: 991

Group type: COMPARATOR
Intervention: Continuous treatment with esomeprazole 20 mg once a day
Number of subjects: 991
Study: 18229542

Group type: EXPERIMENTAL
Intervention: Blocked practice group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random practice group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random-blocked practice group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 14762056

Group type: EXPERIMENTAL
Intervention: Stavudine and Didanosine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Stavudine, Didanosine and Hydroxyurea
Number of subjects: 21
Study: 11713439

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.3 mg/kg/wk)
Number of subjects: 19
Study: 9135362

Group type: EXPERIMENTAL
Intervention: 0.5 MAC of isoflurane with 50% nitrous oxide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.0 MAC of isoflurane with 50% nitrous oxide
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1.0 MAC of isoflurane alone
Number of subjects: 10
Study: 8422091

Group type: EXPERIMENTAL
Intervention: Growth hormone-releasing factor (GH-RF)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 13
Study: 3630291

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase short-term lysis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional heparin phenprocoumon treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (without fibrinolysis)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Early lysis (within 4 hours)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Late lysis (4-6 hours)
Number of subjects: 50
Study: 30753101

Group type: EXPERIMENTAL
Intervention: SynGEM (low dose: 140 μg F, 2 mg BLP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SynGEM (high dose: 350 μg F, 5 mg BLP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SynGEM (both doses)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SynGEM
Number of subjects: 48
Study: 28228134

Group type: EXPERIMENTAL
Intervention: ART home delivery by community health workers (CHWs)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard of care (facility-based ART and CHW home visits without ART home delivery)
Number of subjects: 48
Study: 25382428

Group type: EXPERIMENTAL
Intervention: Open‐fit hearing aids with the built‐in receiver unit (receiver in the ear)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open‐fit hearing aids with RITE
Number of subjects: 20
Study: 24091921

Group type: EXPERIMENTAL
Intervention: Counselling (Promoting Resilience in Mothers' Emotions)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Parenting support
Number of subjects: 262
Study: 22286619

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 89
Study: 19192578

Group type: EXPERIMENTAL
Intervention: Toothpowder with manual toothbrush
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Toothpowder with finger
Number of subjects: 36

Group type: COMPARATOR
Intervention: Toothpaste with manual toothbrush
Number of subjects: 36

Group type: COMPARATOR
Intervention: Toothpaste with finger
Number of subjects: 36
Study: 17041323

Group type: EXPERIMENTAL
Intervention: lathe‐cut contact lenses (lathe‐cut CL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: cast‐molded contact lenses (cast‐molded CL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: spun‐cast contact lenses (spun‐cast CL)
Number of subjects: 28

Group type: COMPARATOR
Intervention: non‐CL
Number of subjects: 28
Study: 12547950

Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension
Number of subjects: 90

Group type: COMPARATOR
Intervention: Open colposuspension
Number of subjects: 90
Study: 10928526

Group type: EXPERIMENTAL
Intervention: CT fluoroscopy (CTF)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Classic CT-guided procedure (Control)
Number of subjects: 190
Study: 8603242

Group type: EXPERIMENTAL
Intervention: Human corticotropin-releasing factor (hCRF) at doses of 2, 4, and 8 mu g/kg body weight
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Human corticotropin-releasing factor (hCRF) at 8 mu g/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 32
Study: 1394808

Group type: EXPERIMENTAL
Intervention: Intra-arterial administration of methotrexate (MTX), Adriamycin (ADM), and cisplatin (CDDP; IA-MAC)
Number of subjects: 48
Study: 6372133

Group type: EXPERIMENTAL
Intervention: Combination inhaler containing salbutamol and beclomethasone dipropionate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Two separate inhalers containing salbutamol and beclomethasone dipropionate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination inhaler
Number of subjects: 15

Group type: COMPARATOR
Intervention: Separate inhalers
Number of subjects: 15
Study: 31231970

Group type: EXPERIMENTAL
Intervention: Support provision from one partner
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Stable levels of support provision and self-efficacy
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Time-varying self-efficacy
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Lagged association
Number of subjects: 338
Study: 30076800

Group type: EXPERIMENTAL
Intervention: REMOTE-CR (12 weeks of individualized exercise prescription, real-time physiological monitoring, coaching, and behavioral support)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: REMOTE-CR
Number of subjects: 162
Study: 25939017

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral training (CBT)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Relaxation training (RT)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 183
Study: 23680034

Group type: EXPERIMENTAL
Intervention: Helical tomotherapy (HT) for whole-brain irradiation (WBRT) with integrated boost (IB)
Number of subjects: 23
Study: 21368391

Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic training (10-30 minutes of stationary cycling, 3 times a week for 8 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 28
Study: 19357525

Group type: EXPERIMENTAL
Intervention: L-acetylcarnitine + BCAA
Number of subjects: 48

Group type: COMPARATOR
Intervention: BCAA
Number of subjects: 48
Study: 16872787

Group type: EXPERIMENTAL
Intervention: Tailored intervention with booster dose
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Tailored intervention without booster dose
Number of subjects: 657

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 657
Study: 15159241

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4.5 g/d during the first 4 months of lactation)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Higher protein intake (measured as a percentage of energy)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Higher protein intake (measured as g/d)
Number of subjects: 105
Study: 11300751

Group type: EXPERIMENTAL
Intervention: Eltenac gel 1%
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 237
Study: 8184210

Group type: EXPERIMENTAL
Intervention: Right hemisphere teaching condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interhemispherical teaching condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Left hemisphere teaching condition
Number of subjects: 0
Study: 3098772

Group type: EXPERIMENTAL
Intervention: 33 micrograms hCRH
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 micrograms hCRH
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 67 micrograms hCRH
Number of subjects: 12
Study: 30385884

Group type: EXPERIMENTAL
Intervention: Ex‐PRESS implantation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 64
Study: 28495462

Group type: EXPERIMENTAL
Intervention: Internet‐based Cognitive Behaviour Therapy (ICBT), n=127
Number of subjects: 258

Group type: COMPARATOR
Intervention: Standard care (face‐to‐face counselling), n=131
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Internet‐based Cognitive Behaviour Therapy (ICBT)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Standard care (face‐to‐face counselling)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 258
Study: 26376918

Group type: EXPERIMENTAL
Intervention: Tracheotomy tube open with no inner cannula
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tracheotomy tube with Blom valve
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tracheotomy tube with Passy-Muir valve
Number of subjects: 10
Study: 24280079

Group type: EXPERIMENTAL
Intervention: Remote telemonitoring using the Medtronic CareLink Network
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional face-to-face follow-up
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Remote telemonitoring
Number of subjects: 200
Study: 20843737

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF) training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Computerized attention skills training (Control)
Number of subjects: 0
Study: 19058686

Group type: EXPERIMENTAL
Intervention: Light-curing composite
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dual-cured resin composites
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall restorations
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall clinical outcomes
Number of subjects: 34
Study: 16552194

Group type: EXPERIMENTAL
Intervention: Intergel treatment (0.5% ferric hyaluronate gel)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intergel treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 14651424

Group type: EXPERIMENTAL
Intervention: Internal fixation (IF)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Total hip replacement (THR)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both EQ‐5D and SF‐36
Number of subjects: 110
Study: 10961223

Group type: EXPERIMENTAL
Intervention: CT-fluoroscopy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional CT
Number of subjects: 78
Study: 9069663

Group type: EXPERIMENTAL
Intervention: Written cognitive pretraining
Number of subjects: 0

Group type: COMPARATOR
Intervention: General group information (Control)
Number of subjects: 0
Study: 8101302

Group type: EXPERIMENTAL
Intervention: Isoniazid plus vitamin B6
Number of subjects: 118

Group type: COMPARATOR
Intervention: Vitamin B6 alone
Number of subjects: 118
Study: 3550556

Group type: EXPERIMENTAL
Intervention: Endocrine therapy alone
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy and endocrine therapy
Number of subjects: 422
Study: 31250134

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 323
Study: 29750664

Group type: EXPERIMENTAL
Intervention: Chronic Pain Self-Management Program (CPSMP)
Number of subjects: 424
Study: 27613076

Group type: EXPERIMENTAL
Intervention: DFN-02 (10 mg sumatriptan plus 0.20% DDM)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Commercially available intranasal sumatriptan 20 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: 4 mg subcutaneous sumatriptan
Number of subjects: 96

Group type: COMPARATOR
Intervention: 6 mg subcutaneous sumatriptan
Number of subjects: 96
Study: 24165272

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg/day
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Combination of tamsulosin and tadalafil
Number of subjects: 133
Study: 23079535

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz at 80% of rest motor threshold)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 38
Study: 20042256

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate powder (once-daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevelamer hydrochloride tablets (thrice-daily)
Number of subjects: 100
Study: 18946458

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (800 IU/day for adults, 400 IU/day for children) for 60 days
Number of subjects: 102

Group type: COMPARATOR
Intervention: Non-supplemented group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Healthy control
Number of subjects: 102
Study: 15663589

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day oral tibolone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 12673143

Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 microg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11004258

Group type: EXPERIMENTAL
Intervention: Probing of the nasolacrimal system under general anesthesia
Number of subjects: 60
Study: 8842828

Group type: EXPERIMENTAL
Intervention: Dan Communication System (DanCS) boards
Number of subjects: 30
Study: 8471375

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Thiopentone 5 mg kg‐1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 3519225

Group type: EXPERIMENTAL
Intervention: High dose furosemide (120 mg i.v. during the initial 24 hours)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Low dose furosemide (20 mg i.v. during the initial 24 hours)
Number of subjects: 73
Study: 30899230

Group type: EXPERIMENTAL
Intervention: Integrative program consisting of education strategies, direct and indirect contact with people diagnosed with SMD, and skill development, delivered over six face-to-face sessions and two additional sessions with healthcare center directors.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (details not specified in the abstract).
Number of subjects: 210
Study: 30275282

Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Number of subjects: 2476

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2476

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2476